BSE Live
Apr 07, 16:01Prev. Close
666.90
Open Price
659.95
Bid Price (Qty.)
655.00 (2)
Offer Price (Qty.)
670.00 (22)
NSE Live
Apr 08, 09:05Prev. Close
660.10
Open Price
670.90
Bid Price (Qty.)
679.90 (2)
Offer Price (Qty.)
670.90 (18)
| Balance Sheet of Albert David (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | |
| Total Share Capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | |
| Reserves and Surplus | 217.09 | 204.74 | 180.24 | 177.31 | 131.12 | |
| Total Reserves and Surplus | 217.09 | 204.74 | 180.24 | 177.31 | 131.12 | |
| Total Shareholders Funds | 222.80 | 210.45 | 185.95 | 183.01 | 136.83 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1.44 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.04 | 0.99 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 4.50 | 4.73 | 4.72 | 4.59 | 4.36 | |
| Long Term Provisions | 10.45 | 10.06 | 9.74 | 8.87 | 7.23 | |
| Total Non-Current Liabilities | 16.44 | 15.78 | 14.47 | 13.46 | 11.59 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.44 | 27.64 | 30.03 | 20.23 | |
| Trade Payables | 39.78 | 33.06 | 31.75 | 27.34 | 26.55 | |
| Other Current Liabilities | 26.11 | 25.64 | 15.19 | 19.81 | 18.15 | |
| Short Term Provisions | 15.09 | 10.02 | 14.19 | 10.88 | 10.50 | |
| Total Current Liabilities | 80.98 | 69.17 | 88.77 | 88.06 | 75.43 | |
| Total Capital And Liabilities | 320.22 | 295.39 | 289.18 | 284.53 | 223.84 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 88.77 | 77.07 | 82.82 | 86.72 | 44.44 | |
| Intangible Assets | 2.23 | 0.02 | 0.03 | 0.04 | 0.00 | |
| Capital Work-In-Progress | 1.52 | 2.60 | 2.82 | 6.58 | 5.01 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 92.52 | 82.14 | 88.09 | 95.43 | 49.45 | |
| Non-Current Investments | 24.17 | 21.43 | 18.90 | 16.75 | 16.50 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 3.87 | 4.17 | 3.60 | |
| Long Term Loans And Advances | 1.96 | 2.45 | 2.50 | 2.50 | 2.66 | |
| Other Non-Current Assets | 0.67 | 3.03 | 3.86 | 1.74 | 0.00 | |
| Total Non-Current Assets | 119.32 | 109.06 | 117.22 | 120.58 | 72.22 | |
| CURRENT ASSETS | ||||||
| Current Investments | 97.61 | 91.55 | 48.98 | 42.16 | 31.04 | |
| Inventories | 42.72 | 44.06 | 43.21 | 50.66 | 48.54 | |
| Trade Receivables | 30.13 | 22.55 | 27.32 | 33.07 | 35.46 | |
| Cash And Cash Equivalents | 6.75 | 7.13 | 25.66 | 14.79 | 23.17 | |
| Short Term Loans And Advances | 13.52 | 14.50 | 17.57 | 10.06 | 13.31 | |
| OtherCurrentAssets | 10.17 | 6.55 | 9.23 | 13.21 | 0.10 | |
| Total Current Assets | 200.90 | 186.34 | 171.96 | 163.95 | 151.63 | |
| Total Assets | 320.22 | 295.39 | 289.18 | 284.53 | 223.84 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 4.14 | 3.66 | 9.84 | 53.81 | 58.06 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 25.31 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 17.85 | 28.28 | 20.79 | 37.84 | 1.70 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | 26.52 | |
| Other Earnings | 17.66 | 24.98 | 25.74 | 23.37 | 0.66 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 18.70 | 21.43 | 18.90 | 16.75 | 16.50 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 98.48 | 91.55 | 48.98 | 42.16 | 31.04 |
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
08.04.2026
08.04.2026
07.04.2026
Kiran Mazumdar‑Shaw calls for new IPO rules to unlock India’s innovation potential in life sciences
07.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth